BioSpace News Archive

Business

Avadel Pharmaceuticals Reports Third Quarter 2017 Results

Total revenues for the third quarter 2017 were $39.7 million, compared to $32.1 million in the third quarter 2016.

November 8, 2017
·
24 min read
Business

Epigenomics AG: Appointment of Director Reimbursement and Medical Affairs

Epigenomics AG announced today that Nicholas T. Potter, PhD, FACMG has accepted the role of Director of Reimbursement and Medical Affairs effective November 1, 2017.

November 8, 2017
·
3 min read
Business

Intra-Cellular Therapies Reports Third Quarter 2017 Financial Results and Provides Corporate Update

The company reported a net loss of $22.9 million, or $0.53 per share (basic and diluted), for the third quarter of 2017 compared to a net loss of $30.3 million.

November 8, 2017
·
11 min read
Business

Catapult Ventures Appoints Chris Spencer as Venture Partner

Chris Spencer, who becomes the Fund’s fourth Venture Partner, will assess investment opportunities and work with the Fund’s smaller investments to help companies successfully grow, with a particular focus on digital health.

November 8, 2017
·
1 min read
Business

Neuralstem Strengthens Executive Leadership Team With Appointment of Dr. David Recker as Chief Medical Officer

Dr. David Recker is the founding manager of JJK Consulting, a group that advises on pharmaceutical development.

November 8, 2017
·
3 min read
Genetown

Microbot Medical Receives Additional Government Grant for Development of its Self-Cleaning Shunt

The grant provides additional sources to be utilized by the Company for the continued development of the Company’s Self-Cleaning Shunt (“SCS”).

November 8, 2017
·
4 min read
Biognosys Announces a Technological Breakthrough in the Development of Its Next-Generation Proteomics Workflow

Biognosys announced today a breakthrough in the development of its next generation proteomics technology that helps scientists to understand complex biological processes.

November 8, 2017
·
3 min read
Drug Development

AMAG Announces Autologous Cord Blood Cells Improve Motor Function in Some Children With Cerebral Palsy

More than one-third of study participants in Phase 2 Study were Cord Blood Registry (CBR) clients.

November 8, 2017
·
7 min read
Business

Neothetics Provides Business Update and Reports Third Quarter 2017 Financial Results

Net loss for the third quarter of 2017 was $1.8 million, or $0.13 basic and diluted net loss per share, compared to a net loss of $2.4 million.

November 8, 2017
·
10 min read
Business

EyeGate Completes Enrollment in Phase IIb Clinical Trial of EGP-437 for Cataract Surgery

Topline data is expected to be released in the first quarter of 2018.

November 8, 2017
·
4 min read